UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 616

Sortiert nach

Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth

Journal of neurochemistry, 2005-06, Vol.93 (5), p.1157-1167

2005

Volltextzugriff (PDF)

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain

Neuroscience, 2011-08, Vol.189, p.345-358

2011

Volltextzugriff (PDF)

Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease

Journal of neurochemistry, 2006-04, Vol.97 (2), p.527-536

2006

Volltextzugriff (PDF)

Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death

Cell death and differentiation, 2016-02, Vol.23 (2), p.333-346

2016

Volltextzugriff (PDF)

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

Journal of Neural Transmission, 2004-12, Vol.111 (12), p.1543-1573

2004

Volltextzugriff (PDF)

Apomorphine protects against MPTP-induced neurotoxicity in mice

Movement disorders, 1999-07, Vol.14 (4), p.612-618

1999

Volltextzugriff (PDF)

N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2

Journal of Neural Transmission, 2006-01, Vol.113 (1), p.21-32

2006

Volltextzugriff (PDF)

cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs

Journal of Neural Transmission, 2003-12, Vol.110 (12), p.1413-1436

2003

Volltextzugriff (PDF)

Brain iron pathways and their relevance to Parkinson's disease

Journal of neurochemistry, 2001-10, Vol.79 (2), p.225-236

2001

Volltextzugriff (PDF)

Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment

Journal of Neural Transmission, 2007-11, Vol.114 (11), p.1443-1454

2007

Volltextzugriff (PDF)

Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30

Current Alzheimer research, 2010-06, Vol.7 (4), p.300

2010

Volltextzugriff (PDF)

Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine

Journal of neurochemistry, 1996-05, Vol.66 (5), p.2004-2010

1996

Volltextzugriff (PDF)

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

Journal of neurochemistry, 1991-03, Vol.56 (3), p.978-982

1991

Volltextzugriff (PDF)

Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis

Journal of neurochemistry, 1992-09, Vol.59 (3), p.1168-1171

1992

Volltextzugriff (PDF)

Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease

Journal of neurochemistry, 1991-11, Vol.57 (5), p.1609-1614

1991

Volltextzugriff (PDF)

Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L‐DOPA in the rat

British journal of pharmacology, 2006-11, Vol.149 (6), p.647-656

2006

Volltextzugriff (PDF)

The effects of iron deficiency and iron and zinc supplementation on rat hippocampus ferritin

Journal of Neural Transmission, 2002-10, Vol.109 (10), p.1241-1256

2002

Volltextzugriff (PDF)

From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A/B

Mini reviews in medicinal chemistry, 2012-05, Vol.12 (5), p.364

2012

Volltextzugriff (PDF)

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Journal of neurochemistry, 1991-04, Vol.56 (4), p.1441-1444

1991

Volltextzugriff (PDF)

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

Journal of neurochemistry, 1991-12, Vol.57 (6), p.2133-2135

1991

Volltextzugriff (PDF)

Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra

Journal of neurochemistry, 1995-08, Vol.65 (2), p.923-926

1995

Volltextzugriff (PDF)

Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment

Journal of Neural Transmission, 2007-11, Vol.114 (11), p.1455-1455

2007

Volltextzugriff (PDF)

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

Journal of neurochemistry, 1994-09, Vol.63 (3), p.793-807

1994

Volltextzugriff (PDF)

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Journal of Neural Transmission, 1988-10, Vol.74 (3), p.199-205

1988

Volltextzugriff (PDF)

Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety

Journal of neural transmission. Supplementum, 2006 (70), p.457-465

2006

Volltextzugriff (PDF)

1 – 25 von 616

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(581)
Mit Volltextzugriff
(345)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(614)
Japanisch
(68)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(472)
Life Sciences & Biomedicine
(465)
Animals
(394)
Neurosciences & Neurology
(367)
Neurosciences
(355)
Humans
(324)
Rats
(188)
Male
(177)
Biological And Medical Sciences
(159)
Monoamine Oxidase - Metabolism
(117)
Medical Sciences
(111)
Monoamine Oxidase Inhibitors - Pharmacology
(86)
Female
(78)
Brain - Metabolism
(67)
Monoamine Oxidase
(67)
Dopamine - Metabolism
(66)
Pharmacology. Drug Treatments
(65)
Pharmacology & Pharmacy
(62)
Biochemistry & Molecular Biology
(61)
Kinetics
(57)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Green tea polyphenol (–)‐epigallocatechin‐3‐gallate induces neurorescue of long‐term serum‐deprived PC12 cells and promotes neurite outgrowth

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain

Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease

Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death

Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

Apomorphine protects against MPTP-induced neurotoxicity in mice

N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2

cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs

Brain iron pathways and their relevance to Parkinson's disease

Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment

Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30

Nature of Inhibition of Mitochondrial Respiratory Complex I by 6‐Hydroxydopamine

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis

Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease

Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L‐DOPA in the rat

The effects of iron deficiency and iron and zinc supplementation on rat hippocampus ferritin

From antioxidant chelators to site-activated multi-target chelators targeting hypoxia inducing factor, beta-amyloid, acetylcholinesterase and monoamine oxidase A/B

The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in Rats

Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra

Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment

Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety

Suchergebnisse filtern